Abstract:
PURPOSE:To determine the factors that correlate with cylinder size in vaginal brachytherapy (VB) after hysterectomy for endometrial carcinoma. METHODS AND MATERIALS:Patients treated for endometrial cancer from January 1, 2003 to December 31, 2013 were reviewed from a single institution. Patients included underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy followed by high-dose-rate VB with or without external beam pelvic radiotherapy (EBRT). According to institutional guidelines, the vaginal cylinder size selected was the largest diameter cylinder the patient could comfortably accommodate. Patient, tumor, and treatment factors were recorded and compared with cylinder size. RESULTS:Three hundred eighty-one eligible patients were identified, including 121 patients treated with pelvic radiotherapy (RT) before VB and 260 treated with VB alone. On univariate analysis, weight (p = 0.0004), body mass index (BMI) (p = 0.001), and receipt of pelvic RT (p ≤ 0.0001) were the only statistically significant factors correlated with vaginal cylinder size. On multivariate analysis, receipt of EBRT retained significance after adjusting for weight or BMI. In patients receiving VB alone, median cylinder size was 3 cm; after pelvic RT, it was 2.5 cm. CONCLUSIONS:Higher weight and BMI correlated with accommodation of larger cylinder size. Accounting for this, the receipt of EBRT before VB was associated with smaller cylinder size. Dosimetric data show that larger cylinder size provides superior dose distribution. Although historically the VB boost follows EBRT, reversal of this order may be preferred.
journal_name
Brachytherapyjournal_title
Brachytherapyauthors
Rakhra SS,Weaver C,Donnelly ED,Helenowski I,Prescott AE,Strauss JBdoi
10.1016/j.brachy.2016.04.391subject
Has Abstractpub_date
2016-09-01 00:00:00pages
549-53issue
5eissn
1538-4721issn
1873-1449pii
S1538-4721(16)30449-4journal_volume
15pub_type
杂志文章相关文献
Brachytherapy文献大全abstract:PURPOSE:To evaluate dosimetry and source location relative to CT-based dosimetry when performing real-time dynamic permanent prostate brachytherapy (PPB) with inverse treatment planning. METHODS AND MATERIALS:A treatment algorithm for dynamic PPB was developed using inverse treatment planning. The technique utilizes r...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/S1538-4721(03)00134-X
更新日期:2003-01-01 00:00:00
abstract:PURPOSE:In 2012, our institution transitioned from low-dose-rate (LDR) brachytherapy to high dose-rate (HDR) brachytherapy. We report clinical outcomes after brachytherapy for cervical cancer at our institution over a continuous 10-year period. METHODS AND MATERIALS:From 2004 to 2014, 258 women (184 LDR and 74 HDR) we...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.12.005
更新日期:2017-01-01 00:00:00
abstract:PURPOSE:To determine whether potential extraprostatic extension (EPE) of prostate adenocarcinoma is covered by the prescribed dose when permanent 125I implants are planned with a 5-mm treatment margin. METHODS AND MATERIALS:The postimplant dosimetry of 60 consecutive 125I prostate implants was analyzed to determine wh...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2003.09.002
更新日期:2003-01-01 00:00:00
abstract:PURPOSE:To evaluate outcomes after exclusive salvage high-dose-rate (HDR) intraluminal esophageal brachytherapy given to previously irradiated patients with recurrent esophageal cancer. METHODS AND MATERIALS:We reviewed medical records of 30 patients who were treated by salvage HDR brachytherapy for local esophageal c...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2015.02.392
更新日期:2015-07-01 00:00:00
abstract:PURPOSE:To report the preliminary results of transabdominal ultrasound (TAUS)-guided brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Twenty-nine patients with cervical cancer Stage IB-IVA according to The International Federation of Gynecology and Obstetrics staging were treated by radical radiotherapy fr...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.11.001
更新日期:2015-03-01 00:00:00
abstract:PURPOSE:To validate the 2019 NCCN subgroups of favorable- and unfavorable-intermediate risk (IR) prostate cancer among patients treated with brachytherapy, who are underrepresented in the studies used to develop the 2019 NCCN classification. METHODS:We included all 2,705 men treated with I-125 LDR brachytherapy monoth...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.10.005
更新日期:2020-01-01 00:00:00
abstract:PURPOSE:This work quantifies the influence of intrafraction DNA damage repair and cellular repopulation on biologically effective dose (BED) in Ir-192 high-dose-rate brachytherapy for prostate cancer. In addition, it examines the effect of source-decay-induced BED variation for patients treated at different time points...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.04.005
更新日期:2019-01-01 00:00:00
abstract:PURPOSE:In this study, computer modeling was used to compare the relative doses with the bladder, rectum, and bowel when two different brachytherapy modalities were used to treat cervical cancer with a tandem and ovoid applicator. A standard high-dose rate (HDR) (192)Ir treatment plan was compared with a "mixed-source"...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2010.08.009
更新日期:2011-03-01 00:00:00
abstract:PURPOSE:The aim of the study was to evaluate the results of high-dose-rate interstitial brachytherapy (HDR-ISBT) for patients with advanced cervical carcinoma in which intracavitary radiation therapy may result in a suboptimal dose distribution. METHODS AND MATERIALS:Between 1995 and 2005, 25 patients of median age 64...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2008.12.002
更新日期:2009-04-01 00:00:00
abstract:PURPOSE:African American men have historically had poorer prostate cancer biochemical and survival outcomes than Caucasians. However, emerging data suggest nononcologic factors drive much of this disparity. Prior evidence has suggested an association between a transient prostate specific antigen (PSA) bounce and improv...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.08.008
更新日期:2020-01-01 00:00:00
abstract:PURPOSE:The aim of this study was to retrospectively observe and analyze the long-term treatment outcomes for a total of 952 esophageal cancer patients who were treated with (252)Cf neutron brachytherapy (NBT) in combination with external beam radiotherapy (EBRT). METHODS AND MATERIALS:From November 2001 to March 2012...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.03.004
更新日期:2014-09-01 00:00:00
abstract:PURPOSE:To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. METHODS AND MATERIALS:Between 1998 and 2009, 229 patients wer...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2012.05.003
更新日期:2013-01-01 00:00:00
abstract:OBJECTIVES:To determine the relationship between dosimetric parameters obtained on postimplantation Day 0 and biochemical relapse-free survival (bRFS) in patients treated with (125)I transperineal interstitial permanent prostate brachytherapy (TIPPB). METHODS:Two-hundred twenty men with low-risk (n=155, 70.4%), low-vo...
journal_title:Brachytherapy
pub_type: 临床试验,杂志文章
doi:10.1016/j.brachy.2009.04.005
更新日期:2010-01-01 00:00:00
abstract:PURPOSE:In July 2009, American Society of Radiation Oncology (ASTRO) released a consensus statement (CS) to guide patient selection for accelerated partial breast irradiation (APBI). The goal of this study was to examine how practice patterns changed following the guideline's release. METHODS:The Surveillance, Epidemi...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2015.03.003
更新日期:2015-07-01 00:00:00
abstract:PURPOSE:To analyze the dosimetric impact and periprocedural outcomes with a bioabsorbable hydrogel rectal spacer injected during low-dose-rate (LDR) prostate brachytherapy implants. METHODS AND MATERIALS:A consecutive series of 80 patients implanted with stranded I-125 LDR brachytherapy seeds were evaluated, of which ...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.11.002
更新日期:2020-01-01 00:00:00
abstract:PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2017.09.008
更新日期:2018-01-01 00:00:00
abstract:OBJECTIVE:To compare dosimetrically the stereotactic CyberKnife (CK) therapy and multicatheter high-dose-rate (HDR) brachytherapy (BT) for accelerated partial breast irradiation (APBI). METHODS:Treatment plans of 25 patients treated with CK were selected, and additional plans using multicatheter HDR BT were created on...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2020.10.003
更新日期:2020-11-18 00:00:00
abstract:PURPOSE:Permanent LDR brachytherapy and temporary HDR brachytherapy are competitive techniques for clinically localized prostate radiotherapy. Although a randomized trial will likely never be conducted comparing these two forms of brachytherapy, a comparative radiobiological modeling analysis proves useful in understan...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/S1538-4721(02)00101-0
更新日期:2002-01-01 00:00:00
abstract:PURPOSE:The study aimed to analyze the Pro-Qura database in terms of patient implant sequence number for each institution to determine evidence for a dosimetric learning curve. METHODS AND MATERIALS:In the Pro-Qura database, 2833 of a total of 4614 postplans from 57 brachytherapists were analyzed for evidence of a dos...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2006.10.002
更新日期:2007-01-01 00:00:00
abstract:PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2019.05.005
更新日期:2019-01-01 00:00:00
abstract:PURPOSE:If a prostate cancer patient treated with (125)I brachytherapy dies within 12 months after the treatment, prostate removal before cremation is recommended to avoid problems related to radioactivity in the ashes, such as inhalation of airborne particulate matter by crematorium staff or nearby residents. To provi...
journal_title:Brachytherapy
pub_type: 杂志文章,评审
doi:10.1016/j.brachy.2014.08.043
更新日期:2015-03-01 00:00:00
abstract:PURPOSE:With an aim to evaluate and report high dose date interstitial brachytherapy (HDR-ISBT) in vulvar cancers, we undertook this retrospective analysis. METHODS AND MATERIALS:Histologically proven vulvar cancers treated with HDR-ISBT between 2001 and 2016 were analyzed. Radiotherapy details, clinical outcome in te...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.10.003
更新日期:2017-01-01 00:00:00
abstract:PURPOSE:To evaluate the effectiveness of the single-energy metal artifact reduction (SEMAR) technique for improving the accuracy of I-125 seed identification in postimplant computed tomography (CT) after prostate brachytherapy. METHODS AND MATERIALS:Postimplant CT images of 40 patients treated with I-125 prostate brac...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2016.07.006
更新日期:2016-01-01 00:00:00
abstract:PURPOSE:Although high-dose-rate brachytherapy (HDRBT) offers significant advantages over low dose rate brachytherapy, there are scant data on improved local control (LC) and treatment-related complications in patients with recurrent head and neck (H&N) cancers. We report our preliminary results in patients with recurre...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2006.12.001
更新日期:2007-04-01 00:00:00
abstract:PURPOSE:To present recommendations for the use of interstitial brachytherapy in patients with vaginal cancer or recurrent endometrial cancer in the vagina. METHODS:A panel of members of the American Brachytherapy Society reviewed the literature, supplemented that with their clinical experience, and formulated recommen...
journal_title:Brachytherapy
pub_type: 杂志文章,实务指引
doi:10.1016/j.brachy.2011.06.008
更新日期:2012-01-01 00:00:00
abstract:PURPOSE:Dose escalation using high-dose-rate brachytherapy (HDR-BT) is an established treatment method for prostate cancer. First, long-term results were previously published (specific Kiel method). This study aims to evaluate 10-/15-year outcomes of Kiel Protocol 1 (1986-1992). METHODS AND MATERIALS:Conformal externa...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2013.11.002
更新日期:2014-03-01 00:00:00
abstract:PURPOSE:The radioactive gold grain applicator and seeds offer the flexibility necessary for effective use in the treatment of difficult sites of head-and-neck cancers. This study reviews our experience with gold grain (198Au) implants in locally advanced head-and-neck cancer to demonstrate their efficacy and feasibilit...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/s1538-4721(02)00054-5
更新日期:2002-01-01 00:00:00
abstract:PURPOSE:To compare dose-volume histogram variables for the internal and external urinary sphincters (IUS/EUS) with urinary quality of life after prostate brachytherapy. METHODS AND MATERIALS:Subjects were 42 consecutive men from a prospective study of brachytherapy as monotherapy with (125)I for intermediate-risk loca...
journal_title:Brachytherapy
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.brachy.2012.10.006
更新日期:2013-05-01 00:00:00
abstract:PURPOSE:Treatment of locally advanced cervical cancer in patients with a renal graft requires precautions. The graft is usually in a pelvic position, close to the clinical target volume (CTV). Preserving the graft while ensuring local control is a challenge we have faced in two occasions. We report our experience. MET...
journal_title:Brachytherapy
pub_type: 社论
doi:10.1016/j.brachy.2013.11.003
更新日期:2014-01-01 00:00:00
abstract:BACKGROUND AND PURPOSE:Esophageal neoplasm has a poor prognosis, and palliative care remains an important goal of treatment. The purpose of this study was to assess the ability of high-dose-rate brachytherapy (HDRB) to improve dysphagia in 115 patients treated at our institution. METHODS AND MATERIALS:Patients previou...
journal_title:Brachytherapy
pub_type: 杂志文章
doi:10.1016/j.brachy.2014.09.007
更新日期:2015-01-01 00:00:00